New award for buspirone HCL tablets with radha. Ordering period is OCT 3, 2025 to OCT 2, 2026 with four one-year options
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 36E79725D0044
- Awardee
-
Radha Pharmaceuticals Inc. UEI C1S5SQ88KY67
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- 6505--Buspirone RFP Pre-Solicitation · 36E79725R0024 · Posted Apr 3, 2025
- Last date to order 55% complete
- IDV ceiling
- $18,126,658.75
- Award type
- Single award
- Who can order
- All agencies
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 5 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Department of Veterans Affairs National Acquisition Center awarded an indefinite-delivery contract to Radha Pharmaceuticals Inc. for Buspirone HCL tablets with a ceiling of $18,126,658.75 on October 3, 2025. This is a single-award contract with no set-aside.
The contract covers buspirone hydrochloride tablets in multiple strengths (5 mg, 7.5 mg, 10 mg, 15 mg, and 30 mg) supplied to the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, and Indian Health Service through the VA and DoD Pharmaceutical Prime Vendor Programs. Performance occurs across all customer facilities served by these agencies.
The originating solicitation (36E79725R0024) sought a single contractor to provide an uninterrupted supply of various buspirone tablet strengths in child-resistant closures, with estimated annual requirements ranging from 4,390 to 179,623 bottles across dosage levels. The procurement was unrestricted under full and open competition and carries NAICS code 325412 (Pharmaceutical Preparation Manufacturing).
The ordering period runs from October 3, 2025 through October 2, 2026, with four one-year options extending through October 2, 2030. The contract incorporates FAR clause 52.222-90 (diversity and inclusion). Radha Pharmaceuticals is a minority-owned manufacturer and distributor of generic pharmaceuticals serving federal health and military beneficiaries.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36E79725D0044?
36E79725D0044 was awarded to Radha Pharmaceuticals Inc. by National Acquisition Center (Headquarters) on October 3, 2025.
How much is contract 36E79725D0044 worth?
36E79725D0044's own ceiling is $18,126,659.
Who can order from contract 36E79725D0044?
36E79725D0044 is a single award indefinite delivery contract. All agencies can place orders on it.
Was contract 36E79725D0044 competed?
The extent of competition for 36E79725D0044 was full and open competition. The government received 5 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV